Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase

Overview of attention for article published in Annals of Hematology, April 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,838 followers.

Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase. #lymphoma #lymsm https://t.co/k4ok3OKRfZ

07 Nov 2018

Reply Repost Favourite

Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase. by Watanabe J, Makita S, Ito Y, Hatta S, Suzuki T, Yuda S, Maeshima AM, Fukuhara S, Munakata W, Suzuki T, Maruyam…

18 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.